Leukemia cutis in myelodysplastic syndrome and chronic myelomonocytic leukemia patients treated with adjusted dose 5-azacitidine

Eur J Dermatol. 2015 Nov-Dec;25(6):622-3. doi: 10.1684/ejd.2015.2661.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antimetabolites, Antineoplastic / adverse effects
  • Antimetabolites, Antineoplastic / therapeutic use
  • Azacitidine / adverse effects*
  • Azacitidine / therapeutic use
  • Biopsy
  • Follow-Up Studies
  • Humans
  • Leukemia, Myelomonocytic, Chronic / chemically induced*
  • Leukemia, Myelomonocytic, Chronic / diagnosis
  • Male
  • Myelodysplastic Syndromes / diagnosis
  • Myelodysplastic Syndromes / drug therapy*
  • Skin / pathology*
  • Skin Neoplasms / chemically induced*
  • Skin Neoplasms / diagnosis

Substances

  • Antimetabolites, Antineoplastic
  • Azacitidine